10-K/A

FORM 10-K/A

Company: NovaBay Pharmaceuticals, Inc.
Filed: April 12, 2019
Period of Report: December 31, 2018
Accession Number: 0001437749-19-007095

View Document ↗ View on SEC.gov ↗